News – nCAP Medical™

13 Oct 2026

nCAP Medical, Inc. Announces Distribution Agreement with Lovell Government Services, Inc. to Provide NeuroCuple® to Federal Healthcare Systems

Uncategorized

HEBER CITY, Utah, Oct. 13, 2026 - nCAP Medical, Inc. (“nCAP Medical” or the “Company”), a medical technology company developing NeuroCuple®, a non-opioid platform for chronic and post-surgical pain, today announced a distribution agreement with Lovell Government Services, Inc. (“Lovell”), making NeuroCuple accessible to federal healthcare providers by leveraging Lovell's status as a registered vendor with more than 2,000 federal government facilities and customers globally. “Expanding access to NeuroCuple for service members and veterans is a meaningful extension of our mission to help patients live with less pain while addressing the growing need for opioid-sparing pain management solutions,” said Anthony…

29 Jul 2026

nCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple® Provides Meaningful, Opioid-Sparing Pain Relief Immediately Following Total Knee Arthroplasty

Uncategorized

The study, published in the Journal of Arthroplasty, highlighted that the Company’s NeuroCuple® Nanotechnology Device achieved statistically significant reduction in opioid use, pain, and hospital length of stay, as well as clinically significant reductions in postoperative nausea and vomiting (PONV), and rescue antiemetic use following total knee arthroplasty (TKA) HEBER CITY, Utah, June 16, 2026 -- nCAP Medical, Inc. (“nCAP Medical”, or the “Company”), a medical technology company developing NeuroCuple®, a non-opioid platform for chronic and acute pain, today announced the results as published in The Journal of Arthroplasty, demonstrated its NeuroCuple® Nanotechnology Device achieves clinically, statistically, and economically significant reductions in…

09 Jun 2026

Clinical Study Shows NeuroCuple® Reduced Pain and Opioid Use After Knee Replacement Surgery

Journal of Arthroplasty, Published Peer-Reviewed Research

New Evidence for Drug-Free Pain Relief Following Total Knee Replacement A newly published clinical study in The Journal of Arthroplasty has found that NeuroCuple® technology significantly reduced pain and opioid use following total knee replacement surgery. Total knee replacement is one of the most common orthopedic procedures performed worldwide. While the surgery can restore mobility and improve quality of life, many patients experience substantial postoperative pain that often requires opioid medications for relief. Researchers conducted a randomized, placebo-controlled clinical study to evaluate whether NeuroCuple® technology could help reduce pain and decrease reliance on opioid medications during the critical early recovery…

14 Oct 2025

NCAP Medical Delivers Hands-On Clinical Training and Showcases Double-Blind NIH-Funded TKA Study Data at the 2025 ASA Annual Meeting

NCAP Medical, Inc. was proud to exhibit at the 2025 American Society of Anesthesiologists (ASA) Annual Meeting, where we showcased emerging scientific evidence from our ongoing NIH-funded, double-blind randomized study conducted at the University of Pittsburgh Pittsburgh Medical Center (UPMC)..Event information: https://www.asahq.org/Our exhibit featured a comprehensive research overview, including:Preliminary double-blind randomized and sham controlled results from the latest NIH-funded TKA outcomes trialFindings from previous peer-reviewed studies evaluating neuro-capacitive pain modulationOn-site hands-on demonstrations allowing clinicians to evaluate placement, workflow, and usability directlyAbout the NIH-Funded Double-Blind StudyThe ongoing study investigates a non-pharmacologic, neuro-capacitive adjunct for postoperative recovery following primary total knee arthroplasty…

10 Aug 2025

NCAP Medical Presents Preliminary NIH-Funded TKA Study Results at MHSRS 2025

Public Events, Published Peer-Reviewed ResearchPeer-Reviewed Research

NCAP Medical, Inc. is pleased to announce that our Chief Medical Officer, Senthil Sadhasivam, MD, MBA, MPH, presented a scientific poster containing preliminary results from our ongoing NIH-funded total knee arthroplasty (TKA) outcome study, currently being conducted at the University of Pittsburgh Medical Center (UPMC). The work was featured at the Military Health System Research Symposium (MHSRS) — the Department of Defense’s premier multidisciplinary research meeting dedicated to optimizing the health and performance of U.S. service members. The event details can be found at the official MHSRS site:https://mhsrs.health.mil/ Background and Study Rationale Total knee arthroplasty remains one of the most…

23 Oct 2024

A Major Clinical Step Forward: Evaluating the NeuroCuple® Device in Knee Replacement Surgery

ClinicalTrials.gov, Published Peer-Reviewed ResearchClinical Studies, Evidence & References, Peer-Reviewed Studies, Research Highlights

When patients undergo a major procedure like total knee arthroplasty (TKA), managing pain safely is critical. Effective pain relief enables mobilization, shorter hospital stays, fewer complications—and, critically today, less reliance on opioid medications. That’s why the ongoing randomized controlled trial NCT06460350 is so important for the device manufacturer, clinicians, and patients alike. What is the Trial? Name: “NEUROCUPLE™ in TKA Patients to Enhance Pain Management” (ClinicalTrials.gov Identifier: NCT06460350) found here --> ClinicalTrials.gov Design: Randomized (1:1), placebo-controlled trial comparing the NeuroCuple® patch versus a look-alike placebo patch (without the active nano-capacitor array) in patients undergoing primary unilateral TKA. Scope: The device…

28 Nov 2023

Clinical Evidence Update: NeuroCuple® Device Shows Significant Benefits in Postoperative Pain Management

Journal of Clinical Medicine, Published Peer-Reviewed ResearchClinical Studies, Evidence & References, Peer-Reviewed Studies, Research Highlights, Scientific Evidence

As postoperative pain management continues to evolve toward safer and more multimodal strategies, clinicians are seeking non-pharmacologic modalities capable of reducing opioid exposure without compromising analgesia or recovery outcomes. A recent peer-reviewed study published in the Journal of Clinical Medicine provides encouraging evidence that the NeuroCuple® device—a passive, battery-free nano-capacitive patch—may serve as a meaningful adjunct in early postoperative care. 🔗 Study link: https://www.mdpi.com/2077-0383/12/23/7394 Study Design Summary Conducted at UPMC Shadyside, this prospective, randomized, open-label pilot trial evaluated the NeuroCuple® device in opioid-naïve adults undergoing unilateral primary TKA or THA. Key elements: Participants randomized postoperatively to: Standard multimodal analgesia…

13 Sep 2023

A New Approach to Post-Surgical Pain: How a Nano-Tech Device Helped a Knee Replacement Patient Avoid Opioids

Published Peer-Reviewed Research, PubMedEvidence & References, Research Highlights

Recovering from a total knee replacement is not easy. Pain levels are often intense, mobility is limited, and most patients are sent home with a prescription for opioid medications immediately after surgery. While these medications can help, they also bring risks—side effects, such as nausea, vomiting, drowsiness, constipation besides risk for dependence, and sometimes prolonged use long after recovery. Now imagine this:A patient undergoes knee replacement surgery, goes home, uses a simple drug-free patch, and never needs opioids at all. That is exactly what happened in a newly published peer-reviewed case report, where the NeuroCuple® device was used as part…